We’re finalists in the 5th CAEB Santander Awards for Business Innovation
The ceremony for the 5th edition of the Awards of the Confederation of Business Associations of the ...
10 December, 2020-
Next generation medicinesLearn moreWe design and develop drugs based on a novel therapeutic approach called melitherapy. -
A new pharmaceutical perspectiveLearn moreOur drugs are first-in-class molecules which target membrane lipids, instead of acting directly on proteins or DNA like other medicines.
-
Committed
to peopleLearn moreOur goal is to deliver reference treatments for illnesses with unmet medical needs, such as cancer and Alzheimer’s disease.
